Related Experiment Video
Updated: Jun 22, 2026

Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
Phosphoproteomics and cancer research
Keith Ashman1, Elena López Villar
1Biotechnology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), ES-28029 Madrid, Spain. kashman@cnio.es
Abstract:
Protein phosphorylation plays key roles in the regulation of normal and cancer cells. It is a highly dynamic process. Protein kinases are the targets of several new cancer drugs and drug candidates. However, some of the main issues related to new drugs are how they function and the selection of those patients that will likely respond best to a particular treatment regime. There is an urgent need to understand and monitor kinase signalling pathways. Phosphoproteomics requires the enrichment of phosphorylated proteins or peptides from tissue or bodily fluids, and the application of technologies such as mass spectrometry (MS) to the identification and quantification of protein phosphorylation sites. As the field develops it will provide pharmacodynamic readouts of disease states and cellular drug responses in tumour samples. There have been a number of recent advances, but there are still technical hurdles and bioinformatics challenges that need to be addressed.
Insights
Understanding protein phosphorylation is crucial for cancer drug development. Phosphoproteomics helps monitor kinase pathways and patient responses, but faces technical and bioinformatics challenges.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Protein phosphorylation is a dynamic regulatory process vital in normal and cancer cells.
- Protein kinases are key targets for novel cancer therapeutics.
- Challenges exist in understanding drug mechanisms and predicting patient response.
Purpose of the Study:
- To highlight the importance of understanding and monitoring kinase signaling pathways.
- To discuss the role of phosphoproteomics in cancer drug development.
- To identify current technical and bioinformatics challenges in the field.
Main Methods:
- Enrichment of phosphorylated proteins or peptides from biological samples.
- Application of mass spectrometry (MS) for site identification and quantification.
- Analysis of phosphoproteomic data for pharmacodynamic insights.
Main Results:
- Phosphoproteomics offers a way to assess drug efficacy and cellular responses in tumors.
- Recent advancements have been made in phosphoproteomic techniques.
- Technical and bioinformatics hurdles remain significant.
Conclusions:
- Monitoring kinase signaling pathways via phosphoproteomics is essential for targeted cancer therapy.
- Further development is needed to overcome technical and bioinformatics challenges.
- Phosphoproteomics holds promise for personalized medicine in oncology.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...

